Human Mesenchymal Stem Cells: The Present Alternative for High-Incidence Diseases, Even SARS-Cov-2

Table 1

Sources of mesenchymal stem cells and their differentiation potential.

Source	Differentiation potential (cell lineage)	Reference
Bone marrow	(i) Hepatocytes; (ii) Pancreatic cells; (iii) Neuron-like cells; (iv) Cardiomyocytes	[19–22]
Adipose tissue	(i) Neuron-like cells; (ii) Cardiomyocytes; (iii) Hepatocytes; (iv) Pancreatic cells	[22–25]
Dental pulp and other dental tissues	(i) Pancreatic β cell-like cells; (ii) Hepatocytes; (iii) Myocytes; (iv) Pancreatic cells; (v) Neuron-like cells	[26–30]
Umbilical cord blood (UCB) and UC	(i) Hepatocytes; (ii) Pancreatic islet-like cells; (iii) Neurons	[31–33]
Wharton’s jelly	(i) Hepatocytes; (ii) Neurons	[34, 35]
Dermal tissue-derived MSCs	(i) Myocytes	[36]